Market Overview:
Global Monoclonal Antibodies Market size was valued at USD 210 billion in 2022 and is poised to grow from USD 233.1 billion in 2023 to USD 537.19 billion by 2031, growing at a CAGR of 11% in the forecast period (2024-2031). Antibodies produced from a single-cell lineage by cloning a white blood cell are known as monoclonal antibodies (mAbs). Monoclonal antibodies are used for drug development or as drugs to effectively treat different types of diseases. The surge in the incidence of chronic diseases around the world is projected to primarily bolster the demand for monoclonal antibodies over the coming years. High investments in medical research and development and advancements in biotechnology are also predicted to bolster the sales of monoclonal antibodies across the forecast period.
Market Insights:
Monoclonal Antibodies Market Drivers
Surge in Prevalence of Chronic Diseases
Rising incidence of chronic diseases around the world has boosted the demand for novel treatments and therapeutics, which in turn is driving investments in medical R&D. Monoclonal antibodies play a crucial role in R&D for therapeutics of many chronic diseases and this could bolster market growth going forward.
Rising Use in Biopharmaceutical Research
High investments in life science and biotechnology research are projected to boost the demand for monoclonal antibodies over the coming years as they are used for biomarker discovery, target identification, and other important stages of biopharmaceutical research.
Download a detailed overview:
https://www.skyquestt.com/sample-request/monoclonal-antibodies-market
Key Market Segments:
The Global Monoclonal Antibodies Market is segmented based on production type, source, application, end use and region.
In terms of production type, the market is bifurcated into in vivo and in vitro.
Based on application, the market is divided into oncology, autoimmune diseases, infectious diseases, neurological diseases, and others.
Based on source, the market is bifurcated into murine, chimeric, humanized, and human.
In terms of end use, the market is segmented into hospitals, specialty centers, and others.
Based on region, the market is segmented into Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/monoclonal-antibodies-market
Analysis by Source
Monoclonal antibodies sourced from humans are projected to account for a dominant share of the Global Monoclonal Antibodies Market. Monoclonal antibodies derived from humans are less immunogenic and safer for use in any kind of healthcare application as compared to mAbs from other sources. Advancements in genetic engineering and genomics will help this segment maintain its dominance.
Demand for humanized monoclonal antibodies is expected to increase at the fastest CAGR over the coming years. Lower immunogenicity as compared to chimeric mAbs is a key factor promoting market growth via this segment. High investments in biotechnology research will also foster innovation in this segment going forward.
Regional Insights:
North America is estimated to account for a substantial share of the Global Monoclonal Antibodies Market owing to high investments in medical R&D and the presence of key biotechnology companies. Supportive government initiatives to promote cancer research are also estimated to bolster monoclonal antibody demand in this region. The United States is expected to lead the market growth in this region followed by Canada. of a developed healthcare infrastructure in the countries also bolsters North America’s dominance.
Meanwhile, the demand for monoclonal antibodies in the Asia Pacific region is slated to rise at a robust pace over the coming years. Rapidly increasing patient pool of people affected chronic diseases such as cancer and cardiovascular disorders is projected to bolster monoclonal antibody market growth in this region. China, India, Japan, and South Korea are estimated to be the top markets for monoclonal antibody suppliers in this region. High emphasis on healthcare infrastructure development will also favor monoclonal antibody sales in the Asia Pacific region through 2031.
Prominent Players in Monoclonal Antibodies Market:
- Abbott Laboratories
- Johnson & Johnson Services Inc.
- Amgen Inc.
- Pfizer Inc.
- Sanofi S.A.
- AstraZeneca plc
- Bristol Myers Squibb
- Hoffman-La Roche Ltd.
- GlaxoSmithKline plc
- Merck KGaA
- Novo Nordisk A/S
- Novartis
- Bayer AG
- Daiichi Sankyo Company Limited
- Biogen Inc.
- Thermo Fisher Scientific Inc.
- Viatris Inc.
- Eli Lilly and Company
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/monoclonal-antibodies-market
Additional Insights:
Market Penetration: Analysis of the product portfolio of different market players and the status of new product launches.
Product Development/Innovation: Assessment of R&D activities, new product development, and emerging trends.
Market Development: Analysis of regions with high growth potential.
Market Diversification: Assessment of new products, recent developments, and emerging regional markets.
Competitive Landscape: Growth strategies, revenue analysis, and product innovations by market players.
Key Questions Answered in Monoclonal Antibodies Market Report:
What is the global market size of the Monoclonal Antibodies Market?
Who are the key vendors in the Monoclonal Antibodies Market?
What is the key driver of the Monoclonal Antibodies Market?
What is the key market trend for the Monoclonal Antibodies Market?
Which region accounted for the largest share in the Monoclonal Antibodies Market?
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact:
Mr. Jagraj Singh
Skyquest Technology
1 Apache Way,
Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email: [email protected]
Visit Our Website: https://www.skyquestt.com/
